PRCT earnings date and last-quarter result: last quarter miss, P/E -9.73. Updated 2026-07-23.
PROCEPT BioRobotics (PRCT) Research Hub
PROCEPT BioRobotics (PRCT) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 19.83 USD (-0.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.73, market cap 1.01B. This hub links to the full technical, earnings and options research available for PRCT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 19.83 USD (-0.65%) |
| 52-week range | 16.67 USD – 25.45 USD |
| Trend regime | Range |
| 14-day RSI | 62.7 (Bullish) |
| Trailing P/E | -9.73 |
| Market cap | 1.01B |
| Dividend yield | 0.00% |
Available research for PRCT
Covered Call on PRCT: how it works, illustrative setup around the real 19.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PRCT: how it works, illustrative setup around the real 19.83 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PRCT: how it works, illustrative setup around the real 19.83 USD price, max profit/loss, breakeven and when to use it. Educational.
PRCT technical analysis: range, last 19.83 USD, RSI 62.7, 52w range 16.67 USD–25.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PRCT in?
PROCEPT BioRobotics (PRCT) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is PRCT in an uptrend or downtrend?
As of 2026-10-26, PRCT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PRCT's trailing P/E ratio?
PRCT's trailing P/E is -9.73, with a market cap of 1.01B. See the earnings research page for full valuation detail.